NCT06704971 · ACTIVE NOT RECRUITING

Assessing Cognitive Decline at Home

This study is testing whether in-home sensors and AI software can track neuropsychiatric symptoms, things like mood changes, agitation, and daily movement patterns, in people with or at risk for memory problems. Researchers want to see if the sensor data matches clinical assessments filled out by caregivers and doctors. This is an observational study with no assigned phase, meaning no drug or treatment is being given.

You may qualify if

  • Age 65+ years old
  • Any age and ethnicity.
  • With or without, or at risk of mild to moderate dementia and healthy controls.
  • Availability of a study partner (informant) who has contact with the patient at least once a week (this can also be the surrogate/LAR but does not necessarily have to be)

You're excluded if

  • Those with severe mobility impairments
  • participants in non-home settings (skilled nursing facilities, etc.).

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-04-27

View full record on ClinicalTrials.gov

All APOE4 clinical trials